Tempus is a leading AI‑powered precision medicine company that uses one of the world’s largest multimodal clinical and molecular data libraries to personalize patient care and accelerate drug development. By integrating directly into physician workflows and research platforms, Tempus empowers oncologists, cardiologists and life sciences organizations to make data‑driven decisions in real time, improving patient outcomes while transforming the future of healthcare innovation. Tempus has built a vast operating system for healthcare, including over 38 million research records and 7 billion clinical notes, enabling advanced insights for oncology, cardiology and other specialties. Its platforms - such as Tempus Hub for physicians and Tempus Lens for researchers - combine multimodal data with generative AI to improve patient outcomes and accelerate clinical research.
🌐 Website: https://www.tempus.com/
💡 Key Insight: Tempus has built the world's largest library of clinical-molecular data — meaning its AI models are trained on a breadth of real patient cases that no single health system or research institution could assemble independently.
Tempus has clear strengths and limitations worth knowing before committing. Explore all features →
| AI Tool | Precision Medicine & Genomics | AI Clinical Decision Support | Oncology Testing | Multimodal Healthcare Data | Pharma & Clinical Research |
|---|---|---|---|---|---|
| Tempus | Genomic + clinical intelligence | AI-enabled clinical insights | Comprehensive genomic profiling | Clinical, molecular & imaging data | Drug development, trials & data licensing |
| Foundation Medicine | Comprehensive genomic profiling | Biomarker-driven treatment insights | Tissue & liquid biopsy testing | Genomic & clinical data | Companion diagnostics & pharma research |
| Caris Life Sciences | Molecular profiling | AI-driven precision oncology | Tissue & liquid biopsy | Molecular + clinical data | Drug discovery & clinical trials |
| Guardant Health | Liquid biopsy & genomics | Biomarker-based treatment insights | Blood-based cancer testing | Genomic + clinical data | Pharma & clinical development |
| NeoGenomics | Cancer genetic testing | AI-assisted pathology | Molecular & oncology testing | Pathology + genomic data | Pharma services & clinical trials |
| Natera | Genomic testing | AI-supported molecular insights | MRD & oncology testing | Genomic + longitudinal data | Transplant, oncology & women's health |
Tempus does not have a conventional SaaS pricing page covering its healthcare platform. Pricing varies by test, payer and clinical use case. Pricing sourced from the official website. Confirm at https://www.tempus.com/ →
| Plan Name | Pricing | Key Features | Best For | Type |
|---|
Tempus has built a genuinely unique asset in precision medicine — the world's largest multimodal clinical-molecular database, combined with AI that surfaces actionable insights for oncologists, cardiologists and life sciences researchers. For health systems investing in precision medicine programs and life sciences organizations designing AI-enabled trials, Tempus provides capabilities that no other vendor has matched at scale.
Disclosure: All opinions and reviews are entirely our own.
Other Healthcare tools worth exploring. Hover any card to pause scrolling.
Have you used Tempus? Share your experience to help others decide.
Tempus gives me access to a genomic and clinical data library I could never build independently. For my oncology patients, that translates to treatment decisions grounded in evidence from comparable real-world cases.
The clinical trial matching feature identified a trial my patient qualified for that I would not have found through standard channels. That enrollment changed her treatment trajectory.
Tempus's cardiology AI tools have accelerated our risk stratification process. What used to require multiple specialist consultations can now be informed by AI analysis before the first appointment.